RVL Pharmaceuticals plc·4

May 22, 9:21 PM ET

Schaub James 4

4 · RVL Pharmaceuticals plc · Filed May 22, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Schaub James
EVP and COO
Transactions
  • Tax Payment

    Ordinary Shares

    2023-05-18$0.87/sh5,577$4,852524,835 total

Documents

1 file
  • 4
    tm2316485-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT